The proteolytic system of Bifidobacterium animalis subsp. lactis was analyzed, and an intracellular endopeptidase (PepO) was identified and characterized. This work reports the first complete cloning, purification, and characterization of a proteolytic enzyme in Bifidobacterium spp. Aminopeptidase activities (general aminopeptidases, proline iminopeptidase, X-prolyl dipeptidylaminopeptidase) found in cell extracts of B. animalis subsp. lactis were higher for cells that had been grown in a milk-based medium than for those grown in MRS. A high specific proline iminopeptidase activity was observed in B. animalis subsp. lactis. Whole cells and cell wall-bound protein fractions showed no caseinolytic activity; however, the combined action of intracellular proteolytic enzymes could hydrolyze casein fractions rapidly. The endopeptidase activity of B. animalis subsp. lactis was examined in more detail, and the gene encoding an endopeptidase O in B. animalis subsp. lactis was cloned and overexpressed in Escherichia coli. The deduced amino acid sequence for B. animalis subsp. lactis PepO indicated that it is a member of the M13 peptidase family of zinc metallopeptidases and displays 67.4% sequence homology with the predicted PepO protein from Bifidobacterium longum. The recombinant enzyme was shown to be a 74-kDa monomer. Activity of B. animalis subsp. lactis PepO was found with oligopeptide substrates of at least 5 amino acid residues, such as met-enkephalin, and with larger substrates, such as the 23-amino-acid peptide ␣ s1 -casein(f1-23). The predominant peptide bond cleaved by B. animalis subsp. lactis PepO was on the N-terminal side of phenylalanine residues. The enzyme also showed a post-proline secondary cleavage site.Bifidobacteria are gram-positive anaerobic bacteria commonly found in the human intestinal tracts of mammals. Many bifidobacterium-containing dairy products have been developed due to their reported health-promoting effects. These organisms are employed to increase the beneficial properties of fermented milks, infant formulas, cheese, and ice cream (10,28,31,43). One of the strains commonly used in the industry is Bifidobacterium animalis subsp. lactis, which is particularly suitable due to its technological properties such as tolerance to oxygen, acid resistance, and ability to grow in milk-based media (20,30,33).Information in the literature regarding the metabolism of bifidobacteria focuses mainly on their glycolytic capabilities, since these organisms have been reported to grow well on oligosaccharide-based substrates (21, 49). Analysis of the genome sequence of Bifidobacterium longum NCC2705 revealed a large number of predicted proteins specialized for oligosaccharide metabolism (45). Genetic and biochemical characterization of Bifidobacterium glycosyl hydrolases has identified several enzymes that utilize nondigestible oligosaccharides as substrates (19,21,22,26). On the other hand, very little is known about the proteolytic enzyme systems of Bifidobacterium spp. However, analysis of the B. long...
Culture conditions in growth and esterase production by a newly isolated Lactobacillus casei CL96 were investigated using a dextrose-free MRS medium supplemented with different sugars in a 2 l fermentor at different pHs (4.0±9.0) and temperatures (20±50°C). The optimal growth was obtained in basal MRS medium containing 1% (w/v) lactose at pH 7.0 and 30°C. The maximal esterase production was obtained intracellularly during the late logarithmic phase, but during the stationary phase, the esterase activity was released in the culture medium. The enzyme activity was maximal at pH 7.0 and 37°C. Among various substrates (C 2 ±C 16 ) tested, the highest activity was towards C 6 and C 8 . Though the enzyme was produced constitutively, the tributylin induced the enzyme production by 2.5 fold. L. casei CL96 esterase was very active at neutral pH and ambient temperature and might be suitable for biotechnological applications in the dairy industry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.